Marinović Ivana, Marušić Srećko, Mucalo Iva, Mesarić Jasna, Bačić Vrca Vesna
Ivana Marinović, Hospital Pharmacy, University Hospital Dubrava, Av. G. Šuška 6, Zagreb, Croatia,
Croat Med J. 2016 Dec 31;57(6):572-581. doi: 10.3325/cmj.2016.57.572.
To evaluate the clinical pharmacist-led medication reconciliation process in clinical practice by quantifying and analyzing unintentional medication discrepancies at hospital admission.
An observational prospective study was conducted at the Clinical Department of Internal Medicine, University Hospital Dubrava, during a 1-year period (October 2014 - September 2015) as a part of the implementation of Safe Clinical Practice, Medication Reconciliation of the European Network for Patient Safety and Quality of Care Joint Action (PASQ JA) project. Patients older than 18 years taking at least one regular prescription medication were eligible for inclusion. Discrepancies between pharmacists' Best Possible Medication History (BPMH) and physicians' admission orders were detected and communicated directly to the physicians to clarify whether the observed changes in therapy were intentional or unintentional. All discrepancies were discussed by an expert panel and classified according to their potential to cause harm.
In 411 patients included in the study, 1200 medication discrepancies were identified, with 202 (16.8%) being unintentional. One or more unintentional medication discrepancy was found in 148 (35%) patients. The most frequent type of unintentional medication discrepancy was drug omission (63.9%) followed by an incorrect dose (24.2%). More than half (59.9%) of the identified unintentional medication discrepancies had the potential to cause moderate to severe discomfort or clinical deterioration in the patient.
Around 60% of medication errors were assessed as having the potential to threaten the patient safety. Clinical pharmacist-led medication reconciliation was shown to be an important tool in detecting medication discrepancies and preventing adverse patient outcomes. This standardized medication reconciliation process may be widely applicable to other health care organizations and clinical settings.
通过量化和分析入院时无意的用药差异,评估临床药师主导的临床实践中的用药核对过程。
作为欧洲患者安全与医疗质量联合行动(PASQ JA)项目“安全临床实践,用药核对”实施的一部分,于2014年10月至2015年9月在杜布拉瓦大学医院内科进行了一项前瞻性观察研究。年龄在18岁以上且至少服用一种常规处方药的患者符合纳入标准。检测到药师的最佳可能用药史(BPMH)与医生的入院医嘱之间的差异,并直接与医生沟通,以明确观察到的治疗变化是有意还是无意的。所有差异均由专家小组讨论,并根据其造成伤害的可能性进行分类。
在纳入研究的411例患者中,共识别出1200处用药差异,其中202处(16.8%)为无意差异。148例(35%)患者存在一处或多处无意用药差异。最常见的无意用药差异类型是漏服药物(63.9%),其次是剂量错误(24.2%)。超过一半(59.9%)的已识别无意用药差异有可能导致患者出现中度至重度不适或临床病情恶化。
约60%的用药错误被评估为有可能威胁患者安全。临床药师主导的用药核对被证明是检测用药差异和预防不良患者结局的重要工具。这种标准化的用药核对过程可能广泛适用于其他医疗机构和临床环境。